Old medicines, new hope for cancer patients? (opens original article in a new tab)

In Uganda, where cancer cases are rising, researchers are exploring whether existing anti-parasitic drugs like ivermectin and mebendazole could have anti-cancer properties, though clinical trials are needed to confirm their effectiveness.

• Uganda's cancer burden is increasing, with over 37,000 new cases and nearly 28,000 deaths annually.
• Ivermectin and mebendazole, traditionally used for parasites, show potential anti-cancer effects in lab studies but are not yet approved for cancer treatment.
• Researchers emphasize the need for clinical trials to confirm effectiveness, as current evidence comes from pre-clinical studies.